adult attention-deficit/hyperactivity disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The patients met the criteria for ADHD and/or ASD on DSM-5 (APA, 2013). 2. The patients suffering from initial, middle, terminal sleep difficulties, and/or daytime sleepiness 3. the patients who is determined to allow participation in the trial by the judgment of the doctor. 4. ISI>=8
Exclusion criteria
Exclusion criteria: 1. The patients who is difficult to participate continuously in the trial. 2. The patients met the criteria for sleep apnea, narcolepsy, idiopathic hypersomnia, restless legs syndrome, and periodic limb movement disorder (ICSD-3, 2014).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Insomnia Severity Index (ISI); At pre- and post-treatment, and 3-month follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| Sleep diary; during the treatment (5-week) Hospital Anxiety Depression Scale (HADS);At pre- and post-treatment, and 3-month follow-up ADHD self-rating Scale (ASRS);At pre- and post-treatment, and 3-month follow-up Autism-spectrum Quotient (AQ);At pre- and post-treatment, and 3-month follow-up | — |
Countries
Japan
Contacts
Tokyo Kasei University Faculty of Humanities